The relationship between copper and steatosis in Wilson's disease

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 1, 2013, Pages 36-40

  Liggi, Mauro ^a   Murgia, Debora ^a   Civolani, Alberto ^a   Demelia, Enrico ^a   Sorbello, Orazio ^a   Demelia, Luigi ^a  

^a DEPARTMENT OF RADIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; FERRITIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DRY WEIGHT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIVER BIOPSY; LIVER LEVEL; MALE; NONALCOHOLIC FATTY LIVER; WILSON DISEASE;

ADULT; COPPER; FATTY LIVER; FEMALE; GLUCOSE; HEPATOLENTICULAR DEGENERATION; HUMANS; IRON; LIPID METABOLISM; MALE;

EID: 84873148916     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.03.038     Document Type: Article

References (46)

1. Petrukhin K., Lutsenko S., Chernov I., et al. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 1994 Sep, 3(9):1647-1656.
2. Lalioti V., Sandoval I., Cassio D., et al. Molecular pathology of Wilson's disease: a brief. J Hepatol 2010, 53:1151-1153.
3. Ludwig J., Moyer T.P., Rakela J. The liver biopsy diagnosis of Wilson's disease. Methods in pathology. Am J Clin Pathol 1994, 102:443-446.
4. Faa G. The role of the pathologist in the diagnosis and monitoring of Wilson's disease. Pathologica 1996, 88(2):102-110.
5. Cope-Yokoyama S., Finegold M.J., Sturniolo G.C., et al. Wilson disease: Histopathological correlations with treatment on follow-up liver biopsies. World J Gastroenterol 2010, 16(12):1487-1494.
6. Lee R.G. Non-alcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler. Hepatology 1995, 21:1742-1743.
7. Ludwig J., Viggiano T.R., McGill D.B., et al. Non-alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980, 55:434-438.
8. Marchesini G., Brizi M., Morselli-Labate A.M., et al. Association of non-alcoholic fatty liver disease with insulin-resistance. Am J Med 1999, 107:450-455.
9. Pagano G., Pacini G., Musso R., et al. Non-alcoholic steatohepatitis, insulin-resistance, and netabolic syndrome: Further evidence for anetiologic association. Hepatology 2002, 35:367.
10. Younossi Z.M., Gramlich T., Bacon Br, et al. Hepatic iron and non-alcoholic fatty liver disease. Hepatology 1999, 30:847-850.
11. Bacon B.R., Farahvash M.J., Janney C.G., et al. Non-alcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994, 107:1103-1109.
12. Akin K., Beyler A.R., Kaya M., et al. The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis. Turk J Gastroenterol 2003, 14(4):228-233.
13. Johansen K., Gregersen G. Glucose intolerance in Wilson's disease. Normalization after treatment with penicillamine. Arch Intern Med 1972, 129(4):587-590.
14. Demelia L, Solinas A, Lai C et al. A study of carbohydrate metabolism in patients with Wilson disease. Falk Symposium 41, Nutrition in Liver Disease. Freiburg 15-17 June 1984.
15. Bonet Serra B., Henry Knopp R. Type-III hyperlipoproteinemia in a girl with Wilson's disease. An Esp Pediatr 1999, 50(1):71-73.
16. Fan J.G., Jia J.D., Li Y.M., Wang B.Y., et al. Guidelines for the diagnosis and management of non-alcoholic fatty liver disease: update 2010. J Dig Dis 2011, 12(1):38-44.
17. Eve A., Roberts L., Michael L., Schilsky Diagnosis and treatment of wilson disease: an update. AASLD practice guidelines. Hepatology 2008, 47(6):2089-2111.
18. European Association for Study of Liver EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol 2012, 56(3):671-685.
19. Butler P., McIntyre N., Mistry P.K. Molecular diagnosis of Wilson disease. Mol Genet Metab 2001, 72:223-230.
20. Menghini G. One-second needle biopsy of the liver. Gastroenterology 1958, 35(2):190-199.
21. Bassett M.L., Halliday J.W., Powell L.W. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986, 6(1):24-29.
22. Theise N. Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach. Modern Pathology 2007, 20:S3-S14.
23. Brunt E.M. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 2000, 31(1):241-246.
24. Brunt E.M., Janney C.G., Di Bisceglie A.M., et al. Non-alcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
25. Adams L.A., Sanderson S., Lindor K.D., et al. The histological course of non-alcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005, 42:132-138.
26. Brunt E.M., Kleiner D.E., Wilson L.A., et al. The NAS and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011, 53(3):810-820.
27. Hjelkrem M., Stauch C., Shaw J., et al. Validation of the non-alcoholic fatty liver disease activity score. Aliment Pharmacol Ther 2011, 34(2):214-218.
28. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
29. 2) as a measure of fatness. Int J Obes 1985, 9:147-153.
30. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin-resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
31. Medina J., Fernandez-Salazar L.I., Garcia-Buey L., et al. Approach to the pathogenesis and treatment of non-alcoholic steatohepatitis. Diabetes Care 2004, 27(8):2057-2066.
32. Vuppalanchi R., Chalasani N. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 2009, 49:306-317.
33. Angulo P. Non-alcoholic fatty liver disease. N Engl J Med 2002, 346:1221-1231.
34. Bugianesi E., Manzini P., D'Antico S., et al. Relative contribution of iron burden, HFE mutations, and insulin-resistance to fibrosis in non-alcoholic fatty liver. Hepatology 2004, 39:179-187.
35. Powell E.E., Cooksley W.G., Hanson R., et al. The natural history of non-alcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990, 11:74-80.
36. Angulo P., Keach J.C., Batts K.P., et al. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. Hepatology 1999, 30:1356-1362.
37. Hornboll P., Olsen T.S. Fatty changes in the liver: the relation to age, overweight and diabetes mellitus. Acta Pathol Microbiol Immunol Scand A 1982, 90:199-205.
38. Bellentani S., Saccoccio G., Masutti F., et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000, 132:112-117.
39. Maruhama Y., Abe R., Okuguchi F., et al. Interactions of obesity and glucose-stimulated insulin secretion in familial hypertriglyceridemia. Diabetes 1978, 27:682-693.
40. Lonardo A. Fatty liver and non-alcoholic steatohepatitis. Where do we stand and where are we going?. Dig Dis 1999, 17:80-89.
41. Paradis V., Bedossa P. Definition and natural history of metabolic steatosis: histology and cellular aspects. Diabete Metab 2008, 34:638-642.
42. Sternlieb I. Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. Gastroenterology 1968, 55:354-367.
43. Myers B.M., Prendergast F.G., Holman R., et al. Alterations in hepatocyte lysosomes in experimental hepatic copper overload in rats. Gastroenterology 1993, 105(6):1814-1823.
44. Britton R.S. Metal-induced hepatotoxicity. Semin Liver Dis 1996, 16(1):3-13. [Review].
45. Farinati F., Cardin R., D'Inca R., et al. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease. J Lab Clin Med 2003, 141(6):372-377. [ISSN: 0022-2143].
46. Devereaux M.W., O'Brien K., Khandwala R.A. Abnormal hepatic mitochondrial respiration and cytochrome C oxidase activity in rats with long-term copper overload. Gastroenterology 1993, 105(1):178-187.